ACE2/ANG-(1-7)/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer's disease-like phenotypes

Eur J Pharmacol. 2023 May 5:946:175623. doi: 10.1016/j.ejphar.2023.175623. Epub 2023 Mar 4.

Abstract

Activation of the renin-angiotensin system (RAS), by Angiotensin converting enzyme/Angiotensin II/Angiotensin receptor-1 (ACE/Ang II/AT1 R) axis elicits amyloid deposition and cognitive impairment. Furthermore, ACE2 induced release of Ang-(1-7) binds with the Mas receptor and autoinhibits ACE/Ang II/AT1 axis activation. Inhibition of ACE by perindopril has been reported to improve memory in preclinical settings. However, the functional significance and mechanism by which ACE2/Mas receptor regulate cognitive functions and amyloid pathology is not known. The present study is aimed to determine the role of ACE2/Ang-(1-7)/Mas receptor axis in STZ induced rat model of Alzheimer's disease (AD). We have used pharmacological, biochemical and behavioural approaches to identify the role of ACE2/Ang-(1-7)/Mas receptor axis activation on AD-like pathology in both in vitro and invivo models. STZ treatment enhances ROS formation, inflammation markers and NFκB/p65 levels which are associated with reduced ACE2/Mas receptor levels, acetylcholine activity and mitochondrial membrane potential in N2A cells. DIZE mediated ACE2/Ang-(1-7)/Mas receptor axis activation resulted in reduced ROS generation, astrogliosis, NFκB level and inflammatory molecules and improved mitochondrial functions along with Ca2+ influx in STZ treated N2A cells. Interestingly, DIZE induced activation of ACE2/Mas receptor significantly restored acetylcholine levels and reduced amyloid-beta and phospho-tau deposition in cortex and hippocampus that resulted in improved cognitive function in STZ induced rat model of AD-like phenotypes. Our data indicate that ACE2/Mas receptor activation is sufficient to prevented cognitive impairment and progression of amyloid pathology in STZ induced rat model of AD-like phenotypes. These findings suggest the potential role of ACE2/Ang-(1-7)/Mas axis in AD pathophysiology by regulating inflammation cognitive functions.

Keywords: Ang (1-7); Angiotensin-converting enzyme 2; Inflammation; Mas receptor; Morris water maze; NLRP3.

MeSH terms

  • Acetylcholine
  • Alzheimer Disease* / pathology
  • Angiotensin I / metabolism
  • Angiotensin II / pharmacology
  • Angiotensin-Converting Enzyme 2 / genetics
  • Animals
  • Cognition
  • Inflammation / drug therapy
  • Peptide Fragments / pharmacology
  • Peptidyl-Dipeptidase A / metabolism
  • Phenotype
  • Rats
  • Reactive Oxygen Species
  • Receptors, G-Protein-Coupled / metabolism
  • Streptozocin

Substances

  • Streptozocin
  • Angiotensin-Converting Enzyme 2
  • Reactive Oxygen Species
  • Acetylcholine
  • Peptidyl-Dipeptidase A
  • Peptide Fragments
  • Angiotensin I
  • Receptors, G-Protein-Coupled
  • Angiotensin II